Liquidia (LQDA) Stock
Liquidia (LQDA) closed at $56.73 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.
30 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $56.73
- Nov 17, 2026
- Market cap
- $5.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 22.31 – 93.61
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 55/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Liquidia Corp scores 55/100. Mixed. Strongest on growth and value, financial health is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the t…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| ImmunityBio IncIBRX | 51 | $6.4B |
| Arrowhead Pharmaceuticals Inc.ARWR | 33 | $6.2B |
| Ligand Pharmaceuticals, Inc.LGND | 40 | $6.0B |
| PTC Therapeutics IncPTCT | 57 | $5.1B |
| Dianthus Therapeutics IncDNTH | 63 | $5.0B |
| Edgewise Therapeutics IncEWTX | 69 | $4.8B |
| Cogent Biosciences IncCOGT | 33 | $4.8B |
| Travere Therapeutics IncTVTX | 43 | $4.8B |
| Ionis Pharmaceuticals IncIONS | 27 | $4.7B |
| Definium Therapeutics Inc.DFTX | 50 | $4.1B |
Common questions
What sector and industry is Liquidia in?
Liquidia is in the Healthcare sector and the Drugs industry.
What is Liquidia's Tenet Score?
Liquidia's Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




